StockData
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. (EBS) KPIs and segments

EBSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3074% below fair value
$5.81+0.02 (+0.35%)

Close on Nov 16, 2026Market cap $297.90MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Emergent BioSolutions's business

Emergent BioSolutions's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
MCM Products($M)
16810299.214358.415711717463.4155138108
Commercial Products($M)
52.442.938.474.967.545.365.195.3120119111142
Earlier reporting (last reported 2023)1
Product and services sales, net($M)
227150144222130209189284248292
MCM Product sales($M)
16810299.214358.415711717463.4155138108
Commercial Product sales($M)
52.442.938.474.967.545.365.195.3120119111142
All other revenue($M)
13.911.411.113.71520.312.824.371.326.5
Contracts and grants($M)
7.506.404.909.1010.613.15.40106.6086.706.50
Earlier reporting (last reported 2024)2
MCM Products($M)
11665.653.810532.510849.412635.193.64239.1
Commercial Products($M)
16.216.111.832.331.320.831.948.166.666.46182.1
Earlier reporting (last reported 2024)2
MCM Products($M)
11665.653.810532.510849.412032.393.240.835.2
Commercial Products($M)
16.216.111.832.331.320.831.948.166.666.46182.1
Earlier reporting (last reported 2024)2
Earlier reporting (last reported 2024)3
Remaining performance obligations (RPO)($M)
269248323297270322384279409

27 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-06.

See a number that looks wrong?